Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124924556 | 12492455 | 6 | F | 200408 | 20160629 | 20160623 | 20160707 | EXP | PHHY2016US084447 | SANDOZ | 53.00 | YR | M | Y | 0.00000 | 20160707 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124924556 | 12492455 | 1 | SS | VOLTAREN | DICLOFENAC SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
124924556 | 12492455 | 2 | PS | NAPROXEN. | NAPROXEN | 1 | Unknown | UNK | U | 74140 | |||||||||
124924556 | 12492455 | 3 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | 500 MG, BID | U | 0 | 500 | MG | TABLET | BID | |||||
124924556 | 12492455 | 4 | I | LAMICTAL | LAMOTRIGINE | 1 | Unknown | 25 MG, UNK | U | 0 | 25 | MG | TABLET | ||||||
124924556 | 12492455 | 5 | I | LAMICTAL | LAMOTRIGINE | 1 | Unknown | 100 MG, UNK | U | 0 | 100 | MG | TABLET | ||||||
124924556 | 12492455 | 6 | I | LAMICTAL | LAMOTRIGINE | 1 | Unknown | 300 MG, QD | U | 0 | 300 | MG | TABLET | QD | |||||
124924556 | 12492455 | 7 | I | LAMICTAL | LAMOTRIGINE | 1 | Unknown | 550 MG, QD | U | 0 | 550 | MG | TABLET | QD | |||||
124924556 | 12492455 | 8 | I | LAMICTAL | LAMOTRIGINE | 1 | Unknown | 100 MG AND 25 MG TABLETS | U | 0 | TABLET | ||||||||
124924556 | 12492455 | 9 | I | TYLENOL | ACETAMINOPHEN | 1 | Oral | 1000 MG, PRN | U | 0 | 1000 | MG | |||||||
124924556 | 12492455 | 10 | SS | TYLENOL PM | ACETAMINOPHENDIPHENHYDRAMINE | 1 | Unknown | UNK | U | 0 | |||||||||
124924556 | 12492455 | 11 | C | KLONOPIN | CLONAZEPAM | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124924556 | 12492455 | 1 | Product used for unknown indication |
124924556 | 12492455 | 2 | Product used for unknown indication |
124924556 | 12492455 | 3 | Temporal lobe epilepsy |
124924556 | 12492455 | 4 | Seizure |
124924556 | 12492455 | 9 | Sleep disorder |
124924556 | 12492455 | 10 | Product used for unknown indication |
124924556 | 12492455 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124924556 | 12492455 | HO |
124924556 | 12492455 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124924556 | 12492455 | Appendicectomy | |
124924556 | 12492455 | Brain oedema | |
124924556 | 12492455 | Brain operation | |
124924556 | 12492455 | Carpal tunnel syndrome | |
124924556 | 12492455 | Cerebral lobotomy | |
124924556 | 12492455 | Divorced | |
124924556 | 12492455 | Drug hypersensitivity | |
124924556 | 12492455 | Drug ineffective | |
124924556 | 12492455 | Drug interaction | |
124924556 | 12492455 | Fall | |
124924556 | 12492455 | Fatigue | |
124924556 | 12492455 | Generalised tonic-clonic seizure | |
124924556 | 12492455 | Hernia repair | |
124924556 | 12492455 | Insomnia | |
124924556 | 12492455 | Peripheral nerve lesion | |
124924556 | 12492455 | Renal stone removal | |
124924556 | 12492455 | Seizure | |
124924556 | 12492455 | Shoulder operation | |
124924556 | 12492455 | Spinal fusion surgery | |
124924556 | 12492455 | Spinal operation | |
124924556 | 12492455 | Surgery | |
124924556 | 12492455 | Upper limb fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124924556 | 12492455 | 3 | 199604 | 0 | ||
124924556 | 12492455 | 4 | 2014 | 0 | ||
124924556 | 12492455 | 9 | 200408 | 0 |